Fundraising Fox

Mikhail Kalinichev

Executive at Addex Therapeutics

Geneva, Geneva, Switzerland

Find your path to Mikhail

159 people in our graph share verified history with Mikhail — schools, employers, funds. One of them is your warm intro.

Ben PerryunlockedMikhail: together at Addex Therapeutics (2009–2013)
×11Mikhail: together at Wesleyan University

Executive at Addex Therapeutics

Intro paths

→

In turn, Mikhail can intro founders to Addex Therapeutics's investors below.

Addex Therapeutics's investors · 4

ACORN BIOVENTURESNew York · since 2021New Enterprise Associates (NEA)Menlo Park · $200K – $40M checksSofinnova PartnersParis · $540K – $27M checksSR One Capital ManagementRedwood City · since 2023

Experience

  1. NeurosterixHead of Translational Sciencecurrent2024 — presentGeneva, Switzerland
  2. Addex TherapeuticsHead of Translational Sciencecurrent2021 — presentGeneva, Switzerland
  3. IpsenDirector, in vivo Neurology2015 — 2021Greater Paris Metropolitan Region
  4. LundbeckHead Of Section2014 — 2015Copenhagen Metropolitan Area
  5. Addex TherapeuticsScientific Advisory Board Member2013 — 2014Geneva, Geneva, Switzerland
  6. Addex TherapeuticsAssociate Director, in vivo Pharmacology Research2012 — 2013Geneva, Geneva, Switzerland
  7. Addex TherapeuticsGroup Leader, Behavioral Neuroscience2009 — 2012Geneva, Switzerland

Skills & more

PharmacologyIn Vivo

Languages English · French

  • Venture Capital Executive Program Certificate — University of California, Berkeley, Haas School of Business
  • Design and Interpretation of Clinical Trials — Coursera

From Mikhail's professional profile.

Frequently asked questions

Who is Mikhail Kalinichev?
Executive Officer at Addex Therapeutics
Where does Mikhail Kalinichev work?
Mikhail Kalinichev is Executive at Addex Therapeutics.
Where did Mikhail Kalinichev go to school?
Mikhail Kalinichev studied at Rutgers University–Newark (Doctor of Philosophy (Ph.D.), Neuroscience); Wesleyan University (Psychobiology).

Same school

Also attended Rutgers University–Newark31

Christian JaagBoard Member at CV VCAlejandro MartíVenture Partner at FaberKeith TitanPartner at BDMIChristopher de SouzaDirector at Broadview VenturesCarly LevineSenior Associate at AMR Action FundShirley WangSenior Operating Associate at Metropolitan Partners

+ 25 more

Also attended Wesleyan University137

Jennifer ZimmermanMarketing & Communications at General CatalystDan LynchInvestor at GV (Google Ventures)David SchenkeinInvestor at GV (Google Ventures)Andy WeissmanPartner at Union Square Ventures (USV)Brad BurnhamPartner at Union Square Ventures (USV)Kristen LaguerreExecutive Partner at MPM BioImpact

+ 131 more

Shared employers

Also worked at Neurosterix2

Jean-Philippe RocherExecutive Officer at Addex TherapeuticsRobert LutjensExecutive Officer at Addex Therapeutics

Also worked at Addex Therapeutics6

Ben PerryInvestor at MedicxiJake NunnPartner at SR One Capital ManagementOleg NodelmanFounder and Portfolio Manager at EcoR1 CapitalJean-Philippe RocherExecutive Officer at Addex TherapeuticsRobert LutjensExecutive Officer at Addex TherapeuticsMélanie RouillierVP, Chief Operations Officer & Co-Founder at Elkedonia

Also worked at Ipsen25

Awny FarajallahChief Medical Officer at Takeda VenturesPierce PolakSenior Associate at Fuel VenturesMilenko CicmilVenture Partner at Cure VenturesRenaud GuillermFounder at SIDE-CapitalClement SalqueAssociate at Bioqube VenturesRachel SchillingConsulting at Rock Health

+ 19 more

Also worked at Lundbeck22

Christian Krog-JensenInvestor at Almi InvestJørgen Søberg PetersenSenior Partner at Novo HoldingsCamilla Petrycer HansenPartner at Novo HoldingsEric FloydRegulatory Advisor at 2Flo VenturesErik SteffensenExpert advisor at VÅR VenturesNicolas FavreChief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund

+ 16 more